Nephros Inc

Nephros Inc(NEPH)股票分析

$2.833

-0.236 (-8.32%)收盤時

Loading chart…
最高
3.080
開盤
3.080
成交量加權均價
2.88
成交量
104.01K
市值
22.04M
最低
2.720
成交金額
299.30K
企業價值/稅息折舊攤銷前利潤(TTM)
5.64

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

AI 分析 of Nephros Inc (NEPH)

持有

Nephros Inc is currently not a strong buy due to its low RSI of 16.83, indicating oversold conditions, and a significant 40.36% year-to-date decline. While the company reported record revenue of $6 million in Q2 2026 and a net income increase of over 400% to approximately $1.2 million, the stock's recent performance has been poor, with a 10.63% drop over the last five days. The main risk is its high debt to equity ratio of 6.17%, which could impact financial stability.

估值指標

Nephros Inc(NEPH)目前預期本益比為 0.00,5 年平均預期本益比為 -23.55。

預期本益比

合理
5 年均值 P/E
-23.55
目前P/E
0.00
高估
118.86
低估
-165.96

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
3.79
目前EV/EBITDA
5.64
高估
28.55
低估
-20.97

預期股價營收比

合理
5 年均值 P/S
1.85
目前P/S
1.31
高估
3.01
低估
0.69

Alphio AI 對 NEPH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%NEPH

$3.45

情境價格

基

基準

基準 · 50%NEPH

$2.82

情境價格

悲

悲觀

悲觀 · 25%NEPH

$2.02

情境價格

事件時間軸

2026-08-06 (ET)

18:00:00

Nephros Reports Q2 Revenue of $6.02M

2026-02-13 (ET)

08:20:00

Nephros Enters Puerto Rican Market to Address Water Quality Needs

2025-12-11 (ET)

09:10:00

Nephros Launches Water Institute to Enhance Industry Education

2025-10-08 (ET)

09:11:53

Nephros Introduces New Filter for PFAS Removal

2024-10-24 (ET)

09:09:57

Nephros launches HydraGuard 20" UltraFilter

資訊

NEPH 常見問題 —— 由 Alphio AI 解答

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. It operates in the Industrials sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Nephros Inc is currently not a strong buy due to its low RSI of 16.83, indicating oversold conditions, and a significant 40.36% year-to-date decline. While the company reported record revenue of $6 million in Q2 2026 and a net income increase of over 400% to approximately $1.2 million, the stock's recent performance has been poor, with a 10.63% drop over the last five days. The main risk is its high debt to equity ratio of 6.17%, which could impact financial stability.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易